Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease

Mental health is a significant yet overlooked aspect of inflammatory bowel disease (IBD) patient care, with challenges in determining optimal treatments and psychological health resources. The most common psychological conditions in patients with IBD are anxiety and depression. The increased prevale...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in psychiatry Vol. 12; p. 714057
Main Authors: Hu, Shurong, Chen, Yiping, Chen, Yan, Wang, Caihua
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 08.10.2021
Subjects:
anxiety disorders
depression disorders
diagnose of psychological disorders
inflammatory bowel disease
Psychiatry
psychological treatment
depression disorders
diagnose of psychological disorders
anxiety disorders
psychological treatment
inflammatory bowel disease
ISSN:1664-0640, 1664-0640
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mental health is a significant yet overlooked aspect of inflammatory bowel disease (IBD) patient care, with challenges in determining optimal treatments and psychological health resources. The most common psychological conditions in patients with IBD are anxiety and depression. The increased prevalence of these mental disorders appeals to mental screening of each person diagnosed with IBD at initial consultation. There are simple and clinically viable methods available to screen for mental problems. Psychological methods may be as or even more significant as a therapeutic modality. Herein we discuss the three major areas of psychological co-morbidity in IBD: (1) the prevalence and risk factors associated with anxiety and depression disorders for patients with IBD; (2) diagnosis of psychological disorders for patients with IBD; (3) treatment with patients with IBD and mental disorders. The gastroenterologists are encouraged to screen and treat these patients with IBD and mental disorders, which may improve outcomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Edited by: Andreas Stengel, Charité – Universitätsmedizin Berlin, Germany
This article was submitted to Psychosomatic Medicine, a section of the journal Frontiers in Psychiatry
Reviewed by: Andrew S. Day, University of Otago, New Zealand; Brigida Barberio, University of Padua, Italy
ISSN:1664-0640
1664-0640
DOI:10.3389/fpsyt.2021.714057